Over and above its pain-relieving outcomes, conolidine has demonstrated a positive safety margin in preclinical toxicology assessments. Compared with opioids, which often result in respiratory depression at bigger doses, conolidine hasn't generated indications of considerable respiratory suppression. On top of that, behavioral assessments in murine products suggest an absence https://peterz840kjo7.blogripley.com/profile